Basket tumors research hub

Efficacy of Olaparib in advanced cancers occurring in patients with germline mutations or somatic tumor mutations in homologous recombination genes.A Belgian Precision 2 study

This study looks at how well a drug called Lynparza works in people with advanced cancers. It focuses on patients whose cancer has specific changes (mutations) in certain genes related to how the body repairs itself. Researchers want to see if the drug shrinks tumours and how long the effect lasts.